Improved pH probes may help towards cancer treatments

December 06, 2019

"It is becoming clear that an acid extracellular pH plays an essential role in cancer cell progression, invasiveness and resistance to therapy," explain Yuri Korchev and Yasufumi Takahashi at Nano Life Science Institute of Kanazawa University and Yanjun Zhang at Imperial College London and colleagues at collaborating institutions in the UK, China, Japan and Russia in a recent paper. Despite the growing recognition of the importance of the pH directly surrounding a cell as an indicator of cell health, techniques to measure it so far remain limited in terms of their sensitivity, the spatial resolution they can offer and the speed of response to pH changes. Reporting in Nature Communications, Zhang, Takahashi and Korchev and colleagues describe a nanopipette pH biosensor that is sensitive to changes in pH of less than 0.01 units with a response time of 2 ms and 50 nm spatial resolution.

The researchers originally designed the sensor as a nanopipette ionic field effect transistor - where gates control the flow of ions in the nanopipette instead of electrons. However, while this tackled issues around pH sensitivity and spatial resolution, the device readings still took a few seconds to respond to pH changes due to ionic Coulomb blockade effects hampering the diffusion rate of ions.

The solution Zhang, Takahashi and Korchev and colleagues now propose is to incorporate a zwitterionic membrane to enable faster responses. By using a twin barrel nanopipette with the membrane in just one of the barrels the researchers were able to use the other barrel as a scanning ionic conductance microscope (SICM) for simultaneous topological measurements.

The team tested the device on live cancer cells and showed how the device could pick up on increases in extracellular pH from invasive phenotypes of breast cancer cells that had been deprived of estrogen. They could also detect pH changes from algae exposed to sunlight, caused by the uptake of inorganic carbon in photosynthesis, as well as identifying heterogeneities in aggressive melanoma cells from high-resolution pH maps.

Highlighting the real-time feedback-controlled dynamic 3D mapping of extracellular pH that their tool allows, and the heterogeneities of cancer cells that it can detect "label-free and at subcellular resolution" they conclude, "This method could help with cancer diagnosis, prognosis, and in evaluating acidic pHe [extracellular pH] targeted therapies."


Limitations of previous techniques

The most commonly used pH probes at present are based on microelectrodes that are quite large in comparison to the scale of the pH fluctuations of interest in studies of extracellular pH. Alternatives have been based on changes in the fluorescence of molecules, nuclear magnetic resonance imaging and positron emission computed tomography. However, monitoring fluorescence is subject to background noise and photobleaching, and the other techniques have poor spatial resolution and raise difficulties in quantification because they are based on the distribution of probes within tissue.

By using a nanopipette as an ionic field effect transistor, the researchers were able to overcome most of the issues limiting previous techniques. However mutual same charge repulsion leads to the Coulomb blockade effect, which starts to inhibit the diffusion of positively charged protonated water molecules in the nanopipette and this slows down the response time.

Zwitterionic membrane

A zwitterion is an uncharged molecule containing opposingly charged functional groups. For the zwitterionic membrane in the nanopipette the researchers self-assemble a hydrogel from poly-l-lysine (PLL) and glucose oxidase (GOx), which has advantages in terms of cost and stability. The PLL has positively charged quaternary amine groups and the GOx has a negatively charged carboxylic acid residue group. The presence of glutaraldehyde vapour can then crosslink the resulting PLL/GOx hydrogel.

In neutral pH the zwitterionic membrane presents both positively and negatively charged functional groups but in low pH conditions the positive amine groups dominate so that negative anions preferentially diffuse through the membrane avoiding an ionic Coulomb blockade.

Kanazawa University

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to